Výsledky vyhledávání - "G Lefrançois"

Étude monocentrique de la membrane « hydrolink » (Toray) en hémodialyse sans héparine

Autor: G. Lefrançois

Publikováno v: Néphrologie & Thérapeutique. 15:314

Introduction La membrane « hydrolink » (Toray) a sa surface interne recouverte du copolymere hydrophile hydrolink qui permet l’adsorption d’une couche d’eau et diminue l’agregation plaquettaire. Methodes Cinq patients hemodialyses 3 fois se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a9df40cbae52c92809941d3646e2c701
https://doi.org/10.1016/j.nephro.2019.07.121

Zobrazit plný text záznamu

Optimization of steel floor systems using particle swarm optimization

Autor: Gérard J. Poitras, Gabriel Cormier, G. Lefrançois

Publikováno v: Journal of Constructional Steel Research. 67:1225-1231

Particle swarm optimization (PSO) is used for the design of composite and non-composite steel floor systems. The design problem is the minimization of the mass or the cost of a steel floor configuration subject to constraints related to the Canadian

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0760090f38039e9f47d6b58eaa92ab99
https://doi.org/10.1016/j.jcsr.2011.02.016

Zobrazit plný text záznamu

A Randomized, Double-Blind, Double-Dummy, Safety Crossover Trial Comparing Cumulative Doses up to 96 μg of Formoterol Delivered via an HFA-134a-Propelled pMDI vs. Same Cumulative Doses of Formoterol DPI and Placebo in Asthmatic Patients

Autor: E. Vicaut, E. Guenolé, T. Duvauchelle, G. Lefrançois, M Molimard

Publikováno v: Respiration. 72:28-34

Background: Formoterol’s effects on the cardiovascular system are well known, but whether these effects are altered by the reformulation of inhalers to replace CFC propellants with HFA propellants is not. Objectives: To evaluate the effect of cumul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa4918583b1e0be43464148393838173
https://doi.org/10.1159/000083690

Zobrazit plný text záznamu

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Efficacy Crossover Trial Comparing Formoterol-HFA (pMDI) versus Formoterol-DPI (AerolizerTM) and Placebo (pMDI or AerolizerTM) in Asthmatic Patients

Autor: G. Huchon, G. Lefrançois, J. Bousquet, V. Leclerc, E. Vicaut

Publikováno v: Respiration. 72:6-12

Background: Chlorofluorocarbons (CFCs) have traditionally been used as propellants in pressurized metered- dose inhalers (pMDIs), which are often used to deliver drugs to the lungs for the treatment of reversible obstructive airways diseases. However

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f2feff29f93b4d95a5e5a578a01130ca
https://doi.org/10.1159/000083687

Zobrazit plný text záznamu

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Crossover Trial Evaluating the Efficacy and Safety Profiles of Two Dose Levels (12 and 24 μg) of Formoterol-HFA (pMDI) vs. Those of a Dose Level (24 μg) of Formoterol-DPI (Foradil®/Aerolizer™) and of Placebo (pMDI or Aerolizer) in Moderate to Severe Asthmatic Patients

Autor: J. Bousquet, E. Guenolé, G. Lefrançois, T. Duvauchelle, E. Vicaut

Publikováno v: Respiration. 72:13-19

Background: Chlorofluorocarbons (CFCs) have traditionally been used as propellants in pressurized metered-dose inhalers (pMDIs), which are often used to deliver drugs to the lungs for the treatment of reversible obstructive airways diseases. However,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274180620d5de8c80880ffdca8d278be
https://doi.org/10.1159/000083688

Zobrazit plný text záznamu

Double-Blind, Double-Dummy, Multinational, Multicenter, Parallel-Group Design Clinical Trial of Clinical Non-Inferiority of Formoterol 12 μg/Unit Dose in a b.i.d. Regimen Administered via an HFA-Propellant-pMDI or a Dry Powder Inhaler in a 12-Week Treatment Period of Moderate to Severe Stable Persistent Asthma in Adult Patients

Autor: E. Vicaut, D. Dusser, G. Lefrançois

Publikováno v: Respiration. 72:20-27

Background: Pressurized metered-dose inhalers (pMDIs) have traditionally used CFCs as propellants. However, the worldwide phase-out of CFCs has necessitated the development of new pMDIs that use alternative propellants. One such replacement is the hy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f35111e50ea7f7826dfe273e4c26cbfe
https://doi.org/10.1159/000083689

Zobrazit plný text záznamu

Enquête « Compli’Asthme » : observance thérapeutique et bonne utilisation des médicaments inhalés dans l’asthme perçues par les médecins praticiens

Autor: K. Benmedjahed, G. Lefrançois, D. Dusser, M. Mueser, F. Megas

Publikováno v: Revue de Pneumologie Clinique. 60:158-165

Resume L’enquete transversale « Compli’Asthme », realisee en 2000 avec l’appui de la visite medicale Chiesi SA aupres de 1 758 medecins francais prenant en charge des patients asthmatiques persistants (80 % de generalistes, 20 % de specialist

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3794965b38db93c9888693cde3747567
https://doi.org/10.1016/s0761-8417(04)72091-x

Zobrazit plný text záznamu

Étude randomisée en double aveugle contre placebo de la tritoqualine hypostamine* dans la rhinite allergique perannuelle

Autor: S Prouzeau, D Legallais, A Pradalier, V Hentschel, G Lefrançois

Publikováno v: Revue Française d'Allergologie et d'Immunologie Clinique. 43:175-179

Resume La tritoqualine, inhibiteur in vivo de l’histidine decarboxylase, sans action sur les recepteurs H1 bien que commercialisee depuis nombre d’annees, fait l’objet de cette premiere etude dans les conditions actuelles des bonnes pratiques c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f3abe62dd56dd658c27f40de80032996
https://doi.org/10.1016/s0335-7457(03)00047-9

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání